https://library.axolbio.com/document/axocells-atrial-and-ventricular-cardiomyocytes-electrophysiology-using-hd-mea-coreplate/2026-06-16T09:57:12+01:00https://library.axolbio.com/document/axion-motor-neuron-application-note/2026-06-16T09:59:20+01:00https://library.axolbio.com/document/ipsc-derived-motor-neurons-whitepaper-en-sartorius/2025-10-29T11:12:55+00:00https://library.axolbio.com/document/axocells-ventricular-cardiomyocytes-as-functionally-relevant-cardiotoxicity-models/2026-06-16T10:01:06+01:00https://library.axolbio.com/document/functional-and-pharmacological-differences-between-the-contractility-of-ipsc-derived-atrial-and-ventricular-cardiomyocytes/2025-10-29T11:47:22+00:00https://library.axolbio.com/document/ipsc-derived-cardiomyocytes-for-high-throughput-in-vitro-cardiac-pharmacology-and-cardiotoxicity/2025-10-29T11:10:45+00:00https://library.axolbio.com/document/ipsc-motor-neuron-nmj-models-for-enhancing-breakthroughs-in-als/2025-10-29T11:09:15+00:00https://library.axolbio.com/document/chamber-specific-human-ipsc-derived-cardiomyocytes-for-in-vitro-cardiotoxicity-studies/2025-10-29T11:07:11+00:00https://library.axolbio.com/document/huntingtons-disease-ipscs-derived-striatal-neurons-with-140-cag-repeats-over-a-100-day-culture/2026-02-17T14:43:55+00:00https://library.axolbio.com/document/human-ipsc-derived-motor-neuron-disease-model-for-als-drug-discovery/2025-10-29T11:30:33+00:00https://library.axolbio.com/document/sygnature-discovery-poster-automation-of-ipsc-workflows/2025-10-29T11:02:37+00:00https://library.axolbio.com/document/high-content-ipsc-derived-microglia-inflammatory-model/2025-10-29T11:01:38+00:00https://library.axolbio.com/document/dry-amd-ipsc-models/2025-10-29T11:29:15+00:00https://library.axolbio.com/document/ipsc-derived-microglia-anti-inflammatory/2025-10-29T11:46:19+00:00https://library.axolbio.com/document/tessara-therapeutics-ipsc-derived-ad-organoids/2025-10-29T11:00:02+00:00https://library.axolbio.com/document/evaluation-of-a-new-media-designed-to-drive-improved-maturity-of-ipsc-derived-cardiomyocytes/2025-10-29T11:26:42+00:00https://library.axolbio.com/document/ipsc-derived-cardiomyocytes/2025-10-29T11:25:09+00:00https://library.axolbio.com/document/multiplatform-utility-of-human-ipsc-derived-neuronal-models/2025-10-29T11:21:21+00:00https://library.axolbio.com/document/characterization-of-striatal-neurons-derived-from-140-cag-ipscs-for-huntingtons-disease-modeling/2025-10-29T11:23:40+00:00https://library.axolbio.com/document/creation-of-rues2-cell-lines-carrying-targeted-modifications-at-the-htt-gene/2026-02-17T14:44:20+00:00https://library.axolbio.com/document/differentiation-of-multiple-ipsc/2025-10-29T11:17:59+00:00https://library.axolbio.com/document/establishment-of-a-quality-driven-manufacturing-process-for-ipsc-derived-cells/2025-10-29T11:16:39+00:00https://library.axolbio.com/document/flow-cytometry-within-a-quality-control-process-for-an-ipsc-based-manufacturing-facility/2025-10-29T11:41:18+00:00https://library.axolbio.com/document/validation-tri-culture-mode-for-in-vitro-compound-screening-cortical-neurons-microglia-astrocyte/2025-10-29T11:40:06+00:00https://library.axolbio.com/document/axocells-ipsc-derived-cortical-inhibitory-interneurons/2025-10-29T11:38:36+00:00https://library.axolbio.com/document/in-vitro-model-of-alzheimers-disease-with-patient-derived-ipscs/2025-10-29T11:37:14+00:00https://library.axolbio.com/document/axocells-hipsc-derived-cardiomyocytes-as-a-better-human-model/2025-10-29T11:35:15+00:00https://library.axolbio.com/document/contractility-of-axocells-ipsc-derived-cardiomyocytes/2025-10-29T11:33:39+00:00https://library.axolbio.com/document/axol-stratastem-sad-panel/2026-02-06T16:03:01+00:00https://library.axolbio.com/document/cosmetics-and-dermatology-ebook-august-update/2026-06-16T09:55:24+01:00https://library.axolbio.com/document/physiologically-relevant-in-vitro-retinal-models-for-ophthalmology-drug-discovery-and-safety-testing/2026-02-27T16:54:14+00:00https://library.axolbio.com/document/mps-ipsc-journal/2026-02-03T11:08:44+00:00https://library.axolbio.com/document/myomax-maturation-media-for-more-mature-cardiomyocytes/2026-02-03T11:07:39+00:00https://library.axolbio.com/document/modeling-the-genomic-instability-of-huntingtons-disease-with-ipsc-technology/2026-06-16T09:53:53+01:00https://library.axolbio.com/document/modeling-als-with-ipsc-derived-cells/2026-02-03T11:06:23+00:00https://library.axolbio.com/document/ipsc-technology-for-huntingtons-disease-ebook/2026-06-16T09:51:48+01:00https://library.axolbio.com/document/human-ipsc-derived-motor-neurons-for-als-modeling-on-the-high-throughput-nanion-syncropatch-384-platform/2026-01-21T13:57:03+00:00https://library.axolbio.com/document/a-contractility-platform-for-engineered-3d-muscle-tissues/2026-01-28T11:52:19+00:00https://library.axolbio.com/document/modeling-als-with-ipsc-derived-motor-neurons/2026-03-16T11:24:59+00:00https://library.axolbio.com/document/physiologically-relevant-ipsc-derived-retinal-models-for-ophthalmology-research-drug-discovery/2026-04-29T11:56:37+01:00https://library.axolbio.com/document/physiologically-relevant-human-ipsc-derived-cell-models-and-specialist-services/2026-06-16T09:37:18+01:00